Manu Ohri

Insider Reports History

Entity
Individual
Location
2355 Main Street, Suite 120, Irvine, CA
Signature
/s/ Jeff Brown, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Manu Ohri:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GT Biopharma, Inc. CFO & Secretary Common Stock 300K $86.1K $0.29 Aug 11, 2023 By Anarjay Concepts, Inc.
GT Biopharma, Inc. CFO & Secretary Common Stock 50K $14.4K $0.29 Aug 11, 2023 By Ohri Family Revocable Trust U/A Dated 02/10/2020
Axil Brands, Inc. Director Common Stock 10K $1.2K $0.12 Jan 13, 2025 By Anarjay Concepts Inc.
Axil Brands, Inc. Director Common Stock 10K $600 $0.12 Jan 13, 2025 Direct
GT Biopharma, Inc. CFO & Secretary Option to purchase Common Stock 500K Jan 27, 2023 Direct
GT Biopharma, Inc. CFO & Secretary Common Stock 0 $0.29 Aug 11, 2023 Direct

Insider Reports Filed by Manu Ohri

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AXIL Axil Brands, Inc. Jan 13, 2025 1 $0 4 Jan 13, 2025 Director
AXIL Axil Brands, Inc. Feb 14, 2024 1 $0 4 Feb 20, 2024 Director
AXIL Axil Brands, Inc. Feb 14, 2024 0 $0 3 Feb 20, 2024 Director
GTBP GT Biopharma, Inc. Aug 11, 2023 3 $57.4K 4 Aug 15, 2023 CFO & Secretary
GTBP GT Biopharma, Inc. Apr 6, 2023 1 $25K 4 Apr 10, 2023 CFO & Secretary
GTBP GT Biopharma, Inc. Jan 27, 2023 1 $0 4 Feb 1, 2023 Chief Financial Officer
GTBP GT Biopharma, Inc. Jul 15, 2022 4 $0 4 Jul 19, 2022 CFO & Secretary
GTBP GT Biopharma, Inc. Feb 14, 2022 0 $0 3 Feb 18, 2022 Chief Financial Officer